Treatment Outcomes of Fluoroquinolone- Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid
Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2024, v.87 no.2, pp.206-208
https://doi.org/10.4046/trd.2023.0188
Oki Nugraha Putra
(Department of Clinical and Community Pharmacy, Study Program of Pharmacy, Faculty of Medicine, Hang Tuah University, Surabaya)
Telly Purnamasari
(Pre-Clinical and Clinical Studies, National Research and Innovation Agency, Central Jakarta, Indonesia)
Oki,
N.
P.
, &
Telly,
P.
(2024). . Tuberculosis & Respiratory Diseases, 87(2), 206-208, https://doi.org/10.4046/trd.2023.0188